Name
ABX-EGF
This definition applies to
All SEER websites where this term appears
Definition
A human monoclonal antibody that is being used to treat colorectal cancer that has spread to other parts of the body. It is used in patients whose disease has not gotten better during or after treatment with other anticancer drugs. It is also being studied in the treatment of other types of cancer. Monoclonal antibodies are made in the laboratory and can locate and bind to cancer cells. ABX-EGF binds to the epidermal growth factor receptor (EGFR) and may block tumor cell growth.
Resource
Alternate Names
Panitumumab
Vectibix
Abstractor Notes
None
Histology
None
Primary Sites
None